Subsequently, researchers continued to investigate novel analogs of SMAC mimetics, revealing that SMAC mimetic also sensitized breast cancer cells to TRAIL-induced apoptosis treatment [150]. The gene discussed is TNFSF10; the disease is breast carcinoma.